Omada Health (NASDAQ:OMDA) Cut to Hold at Wall Street Zen
Omada Health (NASDAQ:OMDA-Get Free Report)was downgraded by analysts atWall Street Zenfrom a "buy" rating to a "hold" rating in a research note issued to investors on Saturday. Other research analysts have. . .
Omada Health (NASDAQ:OMDA-Get Free Report)was downgraded by analysts atWall Street Zenfrom a "buy" rating to a "hold" rating in a research note issued to investors on Saturday. Other research analysts have also recently issued research reports about the stock. Citizens Jmp upped their price target on shares of Omada Health from $18. 00 to $21. 00 and gave the stock a "market outperform" rating in a report on Friday, May 8th. Evercore reissued an "outperform" rating and set a $20. 00 price objective on shares of Omada Health in a research note on Friday, May 8th. Barclays upped their target price on Omada Health from $18. 00 to $20. 00 and gave the stock an "overweight" rating in a research note on Friday, May 8th. Canaccord Genuity Group set a $24. 00 price target on Omada Health in a report on Friday, May 8th. Finally, BTIG Research initiated coverage on Omada Health in a research report on Friday. They set a "buy" rating and a $30. 00 price target for the company. Eleven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $23. 50. GetOmada Healthalerts:Read Our Latest Stock Analysis on OMDAOmada Health Price PerformanceOmada Health stockopened at $23. 70 on Friday. Omada Health has a one year low of $10. 28 and a one year high of $26. 92. The firm has a market capitalization of $1. 41 billion and a P/E ratio of -87. 78. The business has a fifty day moving average price of $19. 01 and a 200-day moving average price of $15. 66. Omada Health (NASDAQ:OMDA-Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0. 05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0. 08) by $0. 03. The firm had revenue of $78. 05 million for the quarter. Omada Health had a negative net margin of 2. 22% and a negative return on equity of 1. 82%. Sell-side analysts expect that Omada Health will post -0. 01 earnings per share for the current fiscal year. Insider Buying and SellingIn other news, CAO Craig Gracey sold 6,894 shares of the company's stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17. 42, for a total value of $120,093. 48. Following the completion of the transaction, the chief accounting officer directly owned 9,191 shares in the company, valued at approximately $160,107. 22. This represents a 42. 86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed throughthis link. Also, CFO Steven L. Cook sold 33,000 shares of the company's stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $19. 89, for a total value of $656,370. 00. Following the completion of the transaction, the chief financial officer owned 133,359 shares of the company's stock, valued at $2,652,510. 51. The trade was a 19. 84% decrease in their ownership of the stock. TheSEC filingfor this sale provides additional information. Over the last ninety days, insiders sold 193,462 shares of company stock worth $3,927,425. Corporate insiders own 6. 38% of the company's stock. Institutional Trading of Omada HealthHedge funds have recently bought and sold shares of the company. Geode Capital Management LLC bought a new position in Omada Health during the second quarter valued at approximately $637,000. Walleye Capital LLC purchased a new stake in shares of Omada Health in the 2nd quarter valued at $458,000. Ilex Capital Partners UK LLP bought a new position in shares of Omada Health during the 2nd quarter valued at $201,000. Soros Fund Management LLC purchased a new position in Omada Health in the 2nd quarter worth $640,000. Finally, Raymond James Financial Inc. bought a new stake in Omada Health in the second quarter worth $32,000. About Omada Health(Get Free Report)Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching. In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management. See AlsoFive stocks we like better than Omada HealthAST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space SectorAehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue GrowthTSMC Just Gave AI Chip Bulls Another Reason to Stay ConfidentGE Aerospace Faces a Prove-It Moment in Q2 EarningsThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Should You Invest $1,000 in Omada Health Right Now?Before you consider Omada Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Omada Health wasn't on the list. While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereThe space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important. Get This Free Report